Rare diseases
Investigational molecules
Locations
Carretera Canyet S/n, 08916 Badalona, Spain
Institut Catala D'oncologia in Badalona, Spain specialises in clinical trials of conditions such as Non-small cell lung cancer, Plasma cell myeloma, Acute myeloid leukaemia, Breast cancer, and other specialisations. This site conducts important research.
Clinical trials currently enrolling participants at this site.
Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
SpainA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
SpainStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
SpainA Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer
SpainStudy on the Safety and Effectiveness of Trastuzumab Deruxtecan vs. Palbociclib-Based Drug Combination for Advanced HR-Positive, HER2-Low Breast Cancer Patients
SpainStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
SpainStudy on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials
SpainRinatabart Sesutecan with or without bevacizumab versus standard platinum‑based chemotherapy drug combination in patients with recurrent platinum‑sensitive ovarian cancer
SpainRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
SpainStudy of Beclometasone Dipropionate in Patients with Asthma to Evaluate Disease Characteristics and Control
SpainPhase 2 Study of Imzokitug with drug combination as First‑Line Treatment for Adults with Locally Advanced or Metastatic Non‑Small Cell Lung Cancer (NSCLC)
SpainLong‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
SpainGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
